|
RP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.56920065619693E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.05070438197686E-11 |
| Normal-vs-Stage2 |
5.564500E-04 |
| Normal-vs-Stage3 |
1.54418999999129E-05 |
| Normal-vs-Stage4 |
1.75591000000086E-05 |
| Stage1-vs-Stage2 |
9.582800E-01 |
| Stage1-vs-Stage3 |
9.890400E-01 |
| Stage1-vs-Stage4 |
4.271200E-01 |
| Stage2-vs-Stage3 |
9.730200E-01 |
| Stage2-vs-Stage4 |
6.847400E-01 |
| Stage3-vs-Stage4 |
5.917600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.03632682832722E-12 |
| Normal-vs-AfricanAmerican |
1.821420E-01 |
| Normal-vs-Asian |
1.290360E-01 |
| Caucasian-vs-AfricanAmerican |
2.01319999999505E-05 |
| Caucasian-vs-Asian |
9.700000E-01 |
| AfricanAmerican-vs-Asian |
1.072820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.21309970349637E-10 |
| Normal-vs-Female |
6.22310003528526E-09 |
| Male-vs-Female |
6.048800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.041400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.66070046603295E-10 |
| Normal-vs-Age(61-80Yrs) |
5.64939994784908E-09 |
| Normal-vs-Age(81-100Yrs) |
2.520400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.532800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.272800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.575800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.817600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.486200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.248780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.203780E-04 |
| Normal-vs-Grade 2 |
2.742199800565E-10 |
| Normal-vs-Grade 3 |
1.55720003558457E-09 |
| Normal-vs-Grade 4 |
2.179100E-03 |
| Grade 1-vs-Grade 2 |
7.747800E-01 |
| Grade 1-vs-Grade 3 |
5.185200E-01 |
| Grade 1-vs-Grade 4 |
2.365200E-01 |
| Grade 2-vs-Grade 3 |
3.188600E-01 |
| Grade 2-vs-Grade 4 |
6.414000E-02 |
| Grade 3-vs-Grade 4 |
1.352790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62725388719309E-12 |
| Normal-vs-ccB subtype |
6.9686000003788E-07 |
| ccA subtype-vs-ccB subtype |
1.816160E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.51280046454406E-10 |
| Normal-vs-N1 |
6.280400E-02 |
| N0-vs-N1 |
9.275600E-01 |
|
|
